US Stock MarketDetailed Quotes

LENZ LENZ Therapeutics

Watchlist
  • 32.630
  • +2.350+7.76%
Close Dec 20 16:00 ET
  • 32.630
  • 0.0000.00%
Post 16:20 ET
897.35MMarket Cap-7.76P/E (TTM)

About LENZ Therapeutics Company

LENZ Therapeutics, Inc. operates as a clinical stage company, which develops ophthalmic pharmaceutical products. It offers eye drop product treatment for presbyopia. The company was founded by James McCollum in July 2013 and is headquartered in Solana Beach, CA.

Company Profile

SymbolLENZ
Company NameLENZ Therapeutics
Listing DateJun 25, 2021
Founded2013
CEOMr. Evert B. Schimmelpennink
MarketNASDAQ
Fiscal Year Ends12-31
Address201 Lomas Santa Fe Drive,Suite 300
CitySolana Beach
ProvinceCalifornia
CountryUnited States of America
Zip Code92075
Phone1-858-925-7000
Websitehttp://www.lenz-tx.com

Company Executives

  • Name
  • Position
  • Salary
  • Evert B. Schimmelpennink
  • Director, President, Chief Executive Officer and Secretary
  • --
  • Daniel R. Chevallard
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Shawn Olsson
  • Chief Commercial Officer
  • --
  • Dr. Marc Odrich, M.D.
  • Chief Medical Officer
  • --
  • Jeffrey P. George
  • Chairman of the Board
  • --
  • James McCollum, M.D.
  • Director
  • --
  • Shelley B. Thunen
  • Independent Director
  • --
  • Dr. Zachary Scheiner, PhD
  • Independent Director
  • --
  • Dr. Frederic Guerard, Pharm.D.
  • Independent Director
  • --
  • Dr. Kimberlee Cobleigh Drapkin, PhD
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data